46-60 of 234
Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
Project Oncology®Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Project Oncology®Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Anti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
NeuroFrontiersAnti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
NeuroFrontiersEvaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
NeuroFrontiersBridging the Gap: New Consensus Recommendations for Adult DMD Care
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
NeuroFrontiersTransitioning to Adult Care in DMD: Strategies for Long-Term Support
- advertisement
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
NeuroFrontiersSupporting Adults With DMD: A Guide to Acute and Long-Term Planning
The Complexities of DMD: Optimizing Multidisciplinary Care
NeuroFrontiersThe Complexities of DMD: Optimizing Multidisciplinary Care
Genetics in Schizophrenia Management: Emerging Technological Strategies
On the Frontlines of SchizophreniaGenetics in Schizophrenia Management: Emerging Technological Strategies
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
NeuroFrontiersInvestigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
Next Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
NeuroFrontiersNext Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
NeuroFrontiersDiagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
- advertisement
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
NeuroFrontiersDuchenne Muscular Dystrophy Management: Analyzing Current Approaches
Genetics and Schizophrenia: Key Ethical Considerations
NeuroFrontiersGenetics and Schizophrenia: Key Ethical Considerations
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
NeuroFrontiersDevelopments in Duchenne Muscular Dystrophy Care: Examining the Options
